The Science Behind Non Proprietary (Generic) Drug Naming (Part 1)

A two-part series on the technical and strategic considerations, and the legal and regulatory challenges of medical product name development Presented by Brand Institute & Drug Safety Institute, a Subsidiary of Brand Institute. Sophia Fuerst, world-renowned nonproprietary naming expert and President of Drug Safety Institute’s Nonproprietary Naming Division, explains the taxonomy of nonproprietary nomenclature, the […]

The Art Behind Pharmaceutical and Medical Device Brand Naming (Part 2)

A two-part series on the technical and strategic considerations, and the legal and regulatory challenges of medical product name development Presented by Brand Institute & Drug Safety Institute, a Subsidiary of Brand Institute Scott Piergrossi joined BI in 2003. He oversees the company’s Miami-based operations and corporate communications. In the 16 years preceding his current […]

Fundamental Regulations for Life Science Start Ups

FDA Regulations and Good Guidance documents don’t only apply to companies who reached commercialization. It is essential for life science startups to adhere to regulations and follow Best Practices, while also setting themselves up for success by implementing quality infrastructures early in the R&D process. Join us on February 9th, 2021 at 12:00 PM PST […]

Stay In the Loop - Join Our Newsletter